Home › NDC Lookup › RxCUI directory › RxCUI 198086

Phenobarbital 16.2 MG Oral Tablet — RxCUI 198086

RxNorm drug concept · Semantic clinical drug
RxCUI 198086 Semantic clinical drug · SCD ● Current RxNorm concept 85 FDA products 220 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198086
Official namePhenobarbital 16.2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped85
Package NDCs mapped220
Reported Medicaid activity (SDUD)82,656 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenobarbital: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used as a sedative and to control seizures. The tablets and oral solutions cover both. The injections have additional uses, such as short-term insomnia, sedation before surge...
  • Please don't stop on your own. Phenobarbital can cause physical dependence, and stopping suddenly can lead to withdrawal problems like delirium and seizures. If you need to stop, y...
  • No, this is a big one. Alcohol and other sedating drugs add to the drowsiness. Opioid pain medicines combined with phenobarbital can cause dangerously slow breathing, coma and deat...
  • Is it safe to drink alcohol or take pain medicine with it?
📖 Read our full Phenobarbital guide →

🕸️ Concept Web — How Phenobarbital 16.2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Phenobarbital 16.2 MG Oral Tablet RxCUI 198086

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Phenobarbital 8134
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fidoquel 2709580
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Phenobarbital Oral Tablet 373326
    • Phenobarbital Oral Product 1157038
    • Phenobarbital Pill 1157039
    • Phenobarbital Oral Tablet [Fidoquel] 2709584
    • Fidoquel Oral Product 2709582
    • Fidoquel Pill 2709583
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Phenobarbital 16.2 MG 316479
    • Phenobarbital 16.2 MG Oral Tablet [Fidoquel] 2709585
    • Phenobarbital 16.2 MG [Fidoquel] 2709581

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Phenobarbital 16.2 MG SCDC · 316479
  • Phenobarbital Oral Tablet SCDF · 373326
  • Phenobarbital Oral Product SCDG · 1157038
  • Phenobarbital Pill SCDG · 1157039

Brand-Name Concepts

  • Phenobarbital 16.2 MG Oral Tablet [Fidoquel] SBD · 2709585
  • Phenobarbital 16.2 MG [Fidoquel] SBDC · 2709581
  • Phenobarbital Oral Tablet [Fidoquel] SBDF · 2709584
  • Fidoquel Oral Product SBDG · 2709582
  • Fidoquel Pill SBDG · 2709583
  • Fidoquel BN · 2709580

📦 FDA Products & Package NDCs

85 products · 220 package NDCs
220 package NDCs map to RxCUI 198086 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00603-5165-21 100 TABLET in 1 BOTTLE, PLASTIC (0603-5165-21) Phenobarbital Par Health USA, LLC 2002-03-01
00603-5166-21 100 TABLET in 1 BOTTLE, PLASTIC (0603-5166-21) Phenobarbital Par Health USA, LLC 2003-02-01
00603-5167-21 100 TABLET in 1 BOTTLE, PLASTIC (0603-5167-21) Phenobarbital Par Health USA, LLC 2001-12-01
00603-5168-21 100 TABLET in 1 BOTTLE, PLASTIC (0603-5168-21) Phenobarbital Par Health USA, LLC 2001-12-01
13517-0626-01 100 TABLET in 1 BOTTLE, PLASTIC (13517-626-01) Phenobarbital e5 Pharma, LLC 2022-11-30
13517-0627-10 1000 TABLET in 1 BOTTLE, PLASTIC (13517-627-10) Phenobarbital e5 Pharma, LLC 2022-11-30
13811-0304-10 100 TABLET in 1 BOTTLE, PLASTIC (13811-304-10) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0304-52 1000 TABLET in 1 BOTTLE, PLASTIC (13811-304-52) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0305-10 100 TABLET in 1 BOTTLE, PLASTIC (13811-305-10) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0305-52 1000 TABLET in 1 BOTTLE, PLASTIC (13811-305-52) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0306-10 100 TABLET in 1 BOTTLE, PLASTIC (13811-306-10) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0306-52 1000 TABLET in 1 BOTTLE, PLASTIC (13811-306-52) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0307-10 100 TABLET in 1 BOTTLE, PLASTIC (13811-307-10) Phenobarbital Trigen Laboratories, LLC 2025-04-01
13811-0307-52 1000 TABLET in 1 BOTTLE, PLASTIC (13811-307-52) Phenobarbital Trigen Laboratories, LLC 2025-04-01
16571-0667-01 100 TABLET in 1 BOTTLE (16571-667-01) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0667-10 1000 TABLET in 1 BOTTLE (16571-667-10) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0667-50 500 TABLET in 1 BOTTLE (16571-667-50) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0668-01 100 TABLET in 1 BOTTLE (16571-668-01) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0668-10 1000 TABLET in 1 BOTTLE (16571-668-10) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0668-50 500 TABLET in 1 BOTTLE (16571-668-50) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0671-01 100 TABLET in 1 BOTTLE (16571-671-01) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0671-10 1000 TABLET in 1 BOTTLE (16571-671-10) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0671-50 500 TABLET in 1 BOTTLE (16571-671-50) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0673-01 100 TABLET in 1 BOTTLE (16571-673-01) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0673-10 1000 TABLET in 1 BOTTLE (16571-673-10) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
16571-0673-50 500 TABLET in 1 BOTTLE (16571-673-50) Phenobarbital Rising Pharma Holdings, Inc. 2020-11-01
51672-5326-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5326-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5326-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5326-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5327-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5327-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5327-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5327-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5328-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5328-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5328-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5328-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5329-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5329-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5329-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5329-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5331-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5331-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5331-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5331-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5332-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5332-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5332-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5332-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5333-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5333-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5333-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5333-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5334-01 100 TABLET in 1 BOTTLE, PLASTIC (51672-5334-1) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
51672-5334-03 1000 TABLET in 1 BOTTLE, PLASTIC (51672-5334-3) Phenobarbital Taro Pharmaceuticals U.S.A. Inc. 2024-08-01
62135-0405-12 120 TABLET in 1 BOTTLE (62135-405-12) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0406-60 60 TABLET in 1 BOTTLE (62135-406-60) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0407-60 60 TABLET in 1 BOTTLE (62135-407-60) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0408-30 30 TABLET in 1 BOTTLE (62135-408-30) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0409-05 500 TABLET in 1 BOTTLE (62135-409-05) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0409-12 120 TABLET in 1 BOTTLE (62135-409-12) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0410-05 500 TABLET in 1 BOTTLE (62135-410-05) Phenobarbital Chartwell RX, LLC 2022-09-01
62135-0410-60 60 TABLET in 1 BOTTLE (62135-410-60) Phenobarbital Chartwell RX, LLC 2022-09-01
Observed labelers: Proficient Rx LP (84) · Westminster Pharmaceuticals, LLC (32) · Genus Lifesciences (16) · Taro Pharmaceuticals U.S.A. Inc. (16) · WINDER LABORATORIES, LLC (16) · Chartwell RX, LLC (12) · +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.